Umea, Sweden

Umecrine Ab

Calculating rank
USPTO Granted Patents = 6

% Expired Patents = 83.3



Forward Citations = 16

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Torbjörn Bäckström (6 out of 16 patents)

silverMedal Ming-De Wang (4 out of 5 patents)

bronzeMedal Per Lundgren (4 out of 4 patents)

4.  Gianna Ragagnin (2 out of 4 patents)

5.  Inga-Maj Johansson (2 out of 2 patents)

6.  Torbjorn Backstrom (0 patent)

7.  Torbjoern Baeckstroem (0 patent)

8.  Ming-De Wang (0 patent)

9.  Per Lundgren (0 patent)


6 patents:

Company Overview
Umecrine AB is a clinical stage pharmaceutical company focused on developing novel treatments for stress-related and related conditions. The company's lead candidate, GR3027, aims to address the unmet medical need for effective drugs in gastroenterology and psychiatry by targeting the Cortisol Receptor Modulator (CRMC) system. With a strong pipeline of innovative drug candidates, Umecrine is committed to improving the lives of patients suffering from stress-related disorders.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#6 in Umea

#931 in Sweden

Umea, SE
Umea, Sweden
Forward Citations = 16

5 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Umecrine Ab. Retrieved from https://idiyas.com/company/umecrine-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…